Literature DB >> 2536398

Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinoma.

C H Sung1, C P Hu, H C Hsu, A K Ng, C K Chou, L P Ting, T S Su, S H Han, C M Chang.   

Abstract

Previous reports indicate that human hepatocytes do not express class I and class II MHC antigens. Our analyses on 10 human hepatocellular carcinoma (HCC) cell lines by immunofluorescence tests and RIA, demonstrate that all the human HCC cell lines tested express class I MHC antigens and among them, three poorly differentiated human HCC cell lines also express class II MHC antigens. Results of immunoprecipitation and/or Western blotting experiments indicate similarity in the chemical nature of both the class I and class II MHC antigens expressed by the human HCC cell lines and by a human B lymphoblastoid cell line Raji. Furthermore, a new variant form of class I antigen was detected in some of these HCC cell lines. Immunohistochemical studies of HCC tissues using the peroxidase-antiperoxidase staining method indicated that class I and class II antigens were detectable in 7 out of 11 and 3 out of 11 HCC tissues from patients, respectively. The availability of MHC class I antigen-positive cultured HCC cell lines, including the poorly differentiated lines that also express MHC class II antigen, has provided us with interesting models to study the relationship between expression of MHC antigen and transformation and differentiation of human hepatocytes. These studies will also allow us some insight into the role of MHC class I and class II antigen in the immunosensitivity and immunogenicity of HCC cells to the host-immune response.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536398      PMCID: PMC303697          DOI: 10.1172/JCI113900

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Biosynthesis and intracellular processing of four human melanoma associated antigens.

Authors:  R R Kantor; A P Albino; A K Ng; S Ferrone
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

2.  In vivo induction of H-2K/D antigens by recombinant interferon-gamma.

Authors:  F Momburg; N Koch; P Möller; G Moldenhauer; G J Hämmerling
Journal:  Eur J Immunol       Date:  1986-05       Impact factor: 5.532

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens.

Authors:  V Quaranta; M A Pellegrino; S Ferrone
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

5.  The class I major histocompatibility antigen gene activated in a line of SV40-transformed mouse cells is H-2Dd, not Qa/Tla.

Authors:  P M Brickell; D S Latchman; D Murphy; K Willison; P W Rigby
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

6.  Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma.

Authors:  I Doi
Journal:  Gan       Date:  1976-02

7.  Detection of a secreted form of the murine H-2 class I antigen with an antibody against its predicted carboxyl terminus.

Authors:  W L Maloy; J E Coligan; Y Barra; G Jay
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

8.  Induction of plasma protein secretion in a newly established human hepatoma cell line.

Authors:  C Chang; Y Lin; T W O-Lee; C K Chou; T S Lee; T J Liu; F K P'eng; T Y Chen; C P Hu
Journal:  Mol Cell Biol       Date:  1983-06       Impact factor: 4.272

9.  Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells.

Authors:  P G Natali; P Giacomini; A Bigotti; K Imai; M R Nicotra; A K Ng; S Ferrone
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

10.  Histocompatibility antigens on murine tumors.

Authors:  R S Goodenow; J M Vogel; R L Linsk
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

View more
  14 in total

1.  Snake venom platelet inhibitor (rhodostomin) inhibits cell-attachment.

Authors:  L C Au; H H Lin; G W Teh; S B Lin
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

2.  Pivotal molecules of MHC I pathway in human primary hepatocellular carcinoma.

Authors:  Wei Chen; Mei-Ying Cai; Da-Peng Wei; Xia Wang
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

3.  HLA expression in hepatocellular carcinoma cell lines.

Authors:  A A Wadee; A Paterson; K A Coplan; S G Reddy
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

4.  Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.

Authors:  Carmen Visus; Yangyang Wang; Antonio Lozano-Leon; Robert L Ferris; Susan Silver; Miroslaw J Szczepanski; Randall E Brand; Cristina R Ferrone; Theresa L Whiteside; Soldano Ferrone; Albert B DeLeo; Xinhui Wang
Journal:  Clin Cancer Res       Date:  2011-08-19       Impact factor: 12.531

5.  CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches.

Authors:  Elise Ramia; Anna Maria Chiaravalli; Farah Bou Nasser Eddine; Alessandra Tedeschi; Fausto Sessa; Roberto S Accolla; Greta Forlani
Journal:  Oncoimmunology       Date:  2018-11-26       Impact factor: 8.110

6.  HLA class I expression in primary hepatocellular carcinoma.

Authors:  Jian Huang; Mei-Ying Cai; Da-Peng Wei
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  Expression of class I MHC molecule, HSP70 and TAP in human hepatocellular carcinoma.

Authors:  Xiao-Ling Deng; Wei Chen; Mei-Ying Cai; Da-Peng Wei
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

8.  Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction.

Authors:  M Paroli; G Carloni; A Franco; G De Petrillo; E Alfani; A Perrone; V Barnaba
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

9.  Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions.

Authors:  Polyxeni P Doumba; Marilena Nikolopoulou; Ilias P Gomatos; Manousos M Konstadoulakis; John Koskinas
Journal:  BMC Gastroenterol       Date:  2013-01-18       Impact factor: 3.067

10.  Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers.

Authors:  Rod Balhorn; Monique Cosman Balhorn
Journal:  Oncotarget       Date:  2020-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.